Complete remission with tyrosine kinase inhibitors in renal cell carcinoma
ContributorsAlbiges, Laurence; Oudard, Stéphane; Negrier, Sylvie; Caty, Armelle; Gravis, Gwenaëlle; Joly, Florence; Duclos, Brigitte; Geoffrois, Lionel; Rolland, Frédéric; Guillot, Aline; Laguerre, Brigitte; Legouffe, Eric; Kohser, Frédéric; Dietrich, Pierre-Yves; Theodore, Christine A; Escudier, Bernard
Published inJournal of clinical oncology, vol. 30, no. 5, p. 482-487
Publication date2012
Abstract
Keywords
- Adult
- Aged
- Antineoplastic Agents/therapeutic use
- Benzenesulfonates/therapeutic use
- Carcinoma, Renal Cell/drug therapy/secondary/surgery
- Feasibility Studies
- Female
- Humans
- Indoles/therapeutic use
- Kidney Neoplasms/drug therapy/pathology/surgery
- Male
- Medical Records
- Middle Aged
- Molecular Targeted Therapy
- Nephrectomy
- Niacinamide/analogs & derivatives
- Phenylurea Compounds
- Protein Kinase Inhibitors/therapeutic use
- Protein-Tyrosine Kinases/antagonists & inhibitors
- Pyridines/therapeutic use
- Pyrroles/therapeutic use
- Questionnaires
- Remission Induction
- Retrospective Studies
- Treatment Outcome
Affiliation
Research group
Citation (ISO format)
ALBIGES, Laurence et al. Complete remission with tyrosine kinase inhibitors in renal cell carcinoma. In: Journal of clinical oncology, 2012, vol. 30, n° 5, p. 482–487. doi: 10.1200/JCO.2011.37.2516
Main files (1)
Article (Published version)
Identifiers
- PID : unige:43569
- DOI : 10.1200/JCO.2011.37.2516
- PMID : 22231040
ISSN of the journal0732-183X
